Boralex Inc Buy Hold or Sell Recommendation

BRLXF -- USA Stock  

USD 16.78  0.00  0.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Boralex Inc Cl A is 'Strong Buy'. Macroaxis provides Boralex Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BRLXF positions. The advice algorithm takes into account all of Boralex Cl A available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BRLXF buy-and-hold prospective. Check also Boralex Inc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Boralex IncBuy Boralex Inc
Strong Buy

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Boralex Inc Cl A has a risk adjusted performance of 0.1673, jensen alpha of 0.1439, total risk alpha of 0.1631, sortino ratio of 0.0 and treynor ratio of 1.57
Our buy or sell advice tool can be used to cross verify current analyst consensus on Boralex Cl A and to analyze the company potential to grow in the current economic cycle. To make sure Boralex Inc is not overpriced, please confirm all Boralex Cl A fundamentals including its Cash and Equivalents as well as the relationship between Book Value Per Share and Market Capitalization . Given that Boralex Cl A has Price to Sales of 3.49 , we suggest you validate Boralex Inc Cl A market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Boralex Inc Trading Alerts and Improvement Suggestions

Boralex Cl A has high likelihood to experience some financial distress in the next 2 years
Boralex Cl A has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported revenue of 346.54 M. Net Loss for the year was (12.03 M) with profit before overhead, payroll, taxes, and interest of 346 M.
Latest headline from mesaweekly.com: -0.31 EPS Expected for Boralex Inc. Alyeska Investment Group LP Has Boosted Agios Pharmaceuticals Position - MS Wkly

Boralex Inc Returns Distribution Density

Mean Return0.15Value At Risk0.13
Potential Upside1.19Standard Deviation0.88
 Return Density 
      Distribution 

Boralex Inc Greeks

α
Alpha over DOW
=0.14
β
Beta against DOW=0.09
σ
Overall volatility
=0.90
Ir
Information ratio =0.19

Boralex Inc Volatility Alert

Boralex Inc Cl A exhibits very low volatility with skewness of 4.0 and kurtosis of 18.64. However, we advise investors to further study Boralex Inc Cl A technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare Boralex Inc to competition

Boralex Inc Fundamental Vs Peers

FundamentalsBoralex IncPeer Average
Return On Equity(2.35) (0.31) 
Return On Asset1.15 (0.14) 
Profit Margin(2.28) (1.27) 
Current Valuation1.5 B16.62 B
Shares Outstanding89.25 M571.82 M
Price to Book2.25 9.51 
Price to Sales3.49 11.42 
Revenue346.54 M9.43 B
Gross Profit346 M27.38 B
EBITDA212.74 M3.9 B
Net Income(12.03 M)570.98 M
Cash and Equivalents90.96 M2.7 B
Cash per Share1.02 5.01 
Total Debt2.46 B5.32 B
Debt to Equity436.90 48.70 
Current Ratio1.01 2.16 
Book Value Per Share7.46 1.93 K
Cash Flow from Operations145.83 M971.22 M
Earnings Per Share(0.16) 3.12 
Number of Employees42018.84 K
Beta0.47-0.15
Market Capitalization1.49 B19.03 B
Five Year Return3.28
Last Dividend Paid0.5
Search macroaxis.com